Single intracavernous injection of autologous adipose-derived stem cells for post radical prostatectomy erectile dysfunction - SIPRPED

Following ADSCs administration, the EF was improved in all patients of the treatment group. One month after therapy, all of the patients in the treatment group had an increase in their IEF-5 score. At 6 and 12 months, in this group, the degree of ED was moderate in 3 patients and mild in 4 patients. In the control group, for patients treated only with PDE5i, the ED remains severe all the time No significant side effects were reported by the patients after ADSCs injections